Topics of Discussion:
Through expert interviews, discussions, and market analysis, DCAT Value Chain Insights provides need-to-know information to keep pace with a changing marketplace:
- The Global Pharma Watchlist: Tracking the performance of the global pharmaceutical industry and leading market sectors.
- The CDMO/CMO Report: Market analysis of the key developments and trends in pharmaceutical outsourcing.
- Manufacturing and Supply Lines: The latest in sourcing and the biopharmaceutical/ pharmaceutical manufacturing value chain.
- The Pharma Pulse: Senior executives share the leading issues on their radar and of import to the pharmaceutical industry.
Plus, Top Industry News: To help ensure DCAT members never miss the most important stories impacting the global biopharmaceutical/pharmaceutical manufacturing value chain, DCAT delivers each Friday, the week’s Top Industry News, a companion newsletter to DCAT Value Chain Insights that highlights the top news stories of the week.
Have questions? Contact DCAT’s Editorial Director, Patricia Van Arnum, This email address is being protected from spambots. You need JavaScript enabled to view it., +1.609.208.1888 Ext 7014
DCAT Value Chain Insights 2021 Editorial Calendar: January–December 2021
| Issue Date | Topic |
| January 6 | The Global Pharma Watchlist: Global Pharma Outlook Analysts provide an outlook on pharmaceutical industry performance for 2021 and beyond. |
| January 13 | The CDMO/CMO Report: The Year Ahead in Pharma Outsourcing Pharma/biopharma outsourcing expert Jim Miller, Content Advisor/Consultant, DCAT, provides an outlook for bio/pharmaceutical outsourcing for 2021. |
| January 20 | Manufacturing and Supply Lines: Fine Chemicals The outlook for fine chemicals supply and demand. |
| January 27 | The Pharma Pulse: What is on the Horizon for 2021? Senior executives give their take on the issues most impactful to the industry for 2021. |
Top Industry News: Jan 8, 15, 22 and 29
|
February 3 |
The Global Pharma Watchlist: Biologics Analysis of the leading products and recent drug approvals for biologic-based drugs. |
| February 10 | The CDMO/CMO Report: Parenteral Drugs A roundup of expansion activity among CDMOs/CMOs for sterile manufacturing, aseptic fill-finish and lyophilization. |
| February 17 | Manufacturing and Supply Lines: API Sourcing Industry roundtable on key trends/issues impacting sourcing for small-molecule active pharmaceutical ingredients (APIs) and intermediates. |
|
February 24 |
The Pharma Pulse: Re-shoring Drug Manufacturing Executives weigh in on policy proposals for re-shoring manufacturing respectively to the US and EU. |
Top Industry News: Feb. 5, 12, 19 and 26
|
March 3 |
The Global Pharma Watchlist: Blockbuster Muscle Analysis and market projections for new drugs, slated for market entry in 2021, with blockbuster potential. |
|
March 10 |
The CDMO/CMO Report: Packaging A roundup of expansions and technology advances in pharma packaging. |
|
March 17 |
Manufacturing and Supply Lines: Inside Big Pharma’s Manufacturing Networks The latest manufacturing expansion activity among the pharmaceutical majors. |
|
March 24 |
The Pharma Pulse: Artificial Intelligence and Supply Management Examining how digital tools, such as AI, are and potentially can be applied in supply management of APIs and drug products. |
|
March 31 |
Special Report: DCAT Benchmarking The results of DCAT’s latest benchmarking study examining topical issues in the pharma customer–supplier relationship. |
Top Industry News: Mar. 5, 12, 19, 26 and Apr. 2
|
April 7 |
The Global Pharma Watchlist: Generics Near-term market outlook for generic drugs. |
|
April 14 |
The CDMO/CMO Report: Biomanufacturing A roundup of expansion activity among CDMOs/CMOs in biomanufacturing. |
| April 21 | Manufacturing and Supply Lines: Small-molecule APIs Supply and demand market overview for small-molecule active pharmaceutical ingredients (APIs). |
| April 28 | The Pharma Pulse: Emerging Pharma Senior executives of bio/pharmaceutical start-ups and Emerging Pharma companies offer their views for successful product development. |
Top Industry News: Apr. 9, 16, 23 and 30
| May 5 | The Global Pharma Watchlist: Pharma in a Post-Brexit World
The impact of Brexit on the pharmaceutical industry. |
| May 12 | The CDMO/CMO Report: Solid-Dosage Drugs
The latest expansions and technology advances, including bioavailability enhancement, from CDMOs/CMOs in solid-dosage development and manufacturing. |
| May 19 | Manufacturing and Supply Lines: Continuous Manufacturing
The latest projects and technology advances in continuous anufacturing for APIs and drug products. |
| May 26 | The Pharma Pulse: Small Molecules and Biologics
Senior pharma executives weigh in on the evolving product mix between small molecules and biologics: current and future trends. |
Top Industry News: May 7, 14, 21 and 28
| June 2 | The Global Pharma Watchlist: Cell and Gene Therapies
Market outlook and manufacturing expansions for cell and gene therapies. |
| June 9 | The CDMO/CMO Report: What’s Trending in Pharma Outsourcing
Pharma/biopharma outsourcing expert Jim Miller, Content Advisor/Consultant, DCAT, analyzes key trends and developments in the CDMO/CMO sector. |
| June 16 | Manufacturing and Supply Lines: Clinical Trial Material Supply
Best practices to optimize clinical trial material supply. |
| June 23 | The Pharma Pulse: The Deal Makers
The top mergers and acquisitions thus far in 2021: the deal-makers and market impact. |
| June 30 | Special Report: New Drug Approvals in 2021
Analysis of the new molecular entity approvals thus far in 2021. |
Top Industry News: June 4, 11, 18, 25 and July 2
| July 7 | The Global Pharma Watchlist: India
Market overview and trends impacting pharmaceutical sourcing from India. |
| July 14 | Virtual DCAT Week, July 12–July 16, 2021, No issue |
| July 21 | Special Report: Virtual DCAT Week Review
Highlights from DCAT’s Member Company Announcement Forum and education programs at Virtual DCAT Week, including a bio/pharma industry outlook and executive insights on manufacturing/supply and drug development. |
| July 28 | The CDMO/CMO Report: Top 10 Moves Thus Far in 2021
A look at the top mergers and acquisitions and expansion news from CDMOs/CMOs thus far in 2021. |
Top Industry News: July 9, 16, 23 and 30
| August 4 | The Global Pharma Watchlist: Biosimilars
Market analysis and outlook for biosimilars. |
| August 11 | The CDMO/CMO Report: Formulation Development/Drug Product Manufacturing
Latest market and technological advances for solid-dosage and parenteral drugs. |
| August 18 | Manufacturing and Supply Lines: China
Market overview and trends impacting pharmaceutical sourcing from China. |
| August 25 | N/A: No issue |
Top Industry News: August 6, 13, 20 and 27
| September 1 | Global Pharma Watchlist: Small-molecule APIs
The top-selling small-molecule drugs and rising contenders. |
| September 8 | The CDMO/CMO Report: End-to-End Service Models
An inside-the-trenches view of the end-to-end service model: CDMOs/CMOs providing both drug-substance and drug-product development and manufacturing. |
| September 15 | Manufacturing and Supply Lines: Biomanufacturing
The latest capacity update and the industry’s fundamentals in biomanufacturing supply and demand. |
| September 22 | The Pharma Pulse: Precision Medicine and Manufacturing
Executives weigh in on manufacturing strategies for lower-volume drugs created by personalized medicines and more targeted therapies. |
| September 29 | Special Report: Global Pharma Pulse
Leading developments from the US, EU, China, India, and Central and South America. |
Top Industry News: September 3, 10, 17, 24 and Oct 1
| October 6 | The Global Pharma Watchlist: Top Pharma Deals in 2021
The leading mergers and acquisitions among pharmaceutical companies thus far in 2021. |
| October 13 | The CDMO/CMO Report: High-Potency Manufacturing
A roundup of recent expansions by CDMOs/CMOs and trends in high-potency manufacturing. |
| October 20 | Manufacturing and Supply Lines: API Sourcing
Industry roundtable on key trends/issues impacting sourcing for small-molecule active pharmaceutical ingredients (APIs) and intermediates. |
| October 27 | The Pharma Pulse: Project Management
Senior executives share case studies in innovation in project management with CDMOs/CMOs. |
Top Industry News: October 8, 15, 22 and 29
| November 3 | The Global Pharma Watchlist: The Key Pipeline Contenders
Late-stage drug candidates with strong market potential. |
| November 10 | The CDMO/CMO Report: Injectable Drugs
Industry roundtable on key trends and technological developments for injectable drugs, including drug-device technology. |
| November 17 | Manufacturing and Supply Lines: Biomanufacturing
The latest biomanufacturing expansions by the pharmaceutical majors. |
| November 24 | N/A: No Issue |
Top Industry News: November 5, 12, 19 and 26
| December 1 | The Global Pharma Watchlist: The Year in Review
A look at the top developments from 2021. |
| December 8 | The CDMO/CMO Report: The Movers and Shakers of 2021
A look at the top expansions and mergers/acquisitions from CDMOs/CMOs in 2021. |
| December 15 | Manufacturing and Supply Lines: Fine Chemicals
Market outlook and key trends in the chemical manufacturing value chain for intermediates and active pharmaceutical ingredients. |
Top Industry News: December 3, 10 and 17
